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Purpose
There are growing concerns of cardiovascular disease in
HIV-infected individuals and in developing countries,
such as Thailand. We described the ten-year risk of cor-
onary heart disease (CHD) in a Thai HIV-infected
cohort using 3 cardiovascular risk equations, and
assessed the level of agreement between their
predictions.
Methods
Cross-sectional analysis of data from 785 Thai subjects
followed prospectively in the HIV Netherlands Australia
Thailand Collaboration (HIV-NAT) cohort study from
1996-2009. Cardiovascular risk factor history, along with
relevant laboratory and clinical data, was collected at
follow-up clinic visits. Ten-year risks of CHD were cal-
culated using the Framingham, Ramathibodi-Electricity
Generating Authority of Thailand (Rama-EGAT), and
Data-collection on Adverse Effects of Anti-HIV Drugs
(D:A:D) risk equations.
Results
Mean age was 41.0 years; 55% of subjects were male.
Mean CD4 count was 569 cells/mm3 after a mean of
7.7 years on anti-retroviral therapy. The prevalence of
cardiovascular risk factors was low, with the most com-
mon risk factor being low high density lipoprotein
(36.3%). The prevalence of high cardiovascular risk
scores (defined as ten-year risk of CHD ≥10%) was also
low: 9.9%, 2.1%, and 0.8%, by the Framingham, Rama-
EGAT, and D:A:D scoring systems, respectively. Only 8
subjects (1.0%) had a history of CHD. Bland-Altman
plots revealed that the Framingham risk score was, on
average, 1.4% (S.D. 3.9%) higher than the Rama-EGAT
and 1.5% (S.D. 3.7%) higher than the D:A:D (Figure 1a,
b). The limits of the difference showed that the Fra-
mingham could be as high as 9.1% above or as low as
6.4% below the Rama-EGAT, and as high as 8.9% above
or as low as 5.9% below the D:A:D. The Bland-Altman
plot comparing the D:A:D and Rama-EGAT equations
(Figure 1c) demonstrated a smaller average difference
(-0.16%) and narrower limits of the difference (-3.9%
and 3.5%). All differences were most pronounced for
subjects with higher average risk scores.
Conclusions
The predicted cardiovascular risk in this HIV-infected
Thai cohort was relatively low. The Framingham equa-
tion predicted the highest cardiovascular risks, which is
consistent with its known tendency to over-predict risk
in Thais. The agreement between the Rama-EGAT and
D:A:D risk scores suggests that both equations may be
appropriate estimators of cardiovascular risk in this and
other developing world populations with low back-
ground risk.
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